Seeking Alpha

Invitrogen Corp. (IVGN)

()

News & PR
Market Currents

Buzz
Twitter: IVGN

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

A Look at D.E. Shaw's Q408 Holdings: Just for Fun

Apr 22 • Market Folly • 2 Comments
Reversal of Stem Cell Research Ban: 13 Stocks to Benefit

Mar 12 • Brian Dean • 9 Comments
Hedge Fund Tracking: Barry Rosenstein's Jana Partners, Q3 2008

Dec 24, 2008 • Market Folly • 3 Comments
Cohen's SAC Boosts Stake in Invitrogen to 6.9%

Jul 30, 2008 • Lon Juricic • Comment!
Biotech Buying Binge About to Begin?

Jul 23, 2008 • Mike Havrilla • 3 Comments
Will M&A Activity Boost PowerShares Dynamic Biotech & Genome ETF?

May 9, 2008 • Don Dion • 1 Comment
Invitrogen: Stock Will Keep Rising

May 4, 2008 • Zacks.com • Comment!
Wall Street Breakfast: Must-Know News

Jan 11, 2008 • SA Editor Judith Levy • Comment!
Biomanufacturing: Evaluating Opportunities in the Froth

Oct 30, 2007 • Andrew Waight • 3 Comments
Nine Stem Cell Stocks to Add to Your Portfolio

Oct 2, 2007 • Stockerblog • 2 Comments
Loeb's Third Point Issues Latest 13F: Summary of Holdings

Aug 16, 2007 • Lon Juricic • Comment!
Thursday's Options Report: VIX, Starbucks, Oil Service Holders, Invitrogen, Pozen, Homebuilders ETF, Sohu, Financial Sector ETF

Aug 2, 2007 • Andrew Wilkinson • Comment!
Investing in Stem Cell Stocks: Growth Industry of the Future?

Feb 21, 2007 • Stockerblog • 12 Comments
Biotech Day In Review: Osiris Stem Cells Treatment Has Unexpected Results

Feb 15, 2007 • Centient Biotech Investor • Comment!
Color On Invitrogen's Quarter

Feb 14, 2007 • Notable Calls • Comment!
Invitrogen Shares Surge on Upside Surprise and Unit Sale

Feb 14, 2007 • SA Editor Judith Levy • Comment!
How Will GE Spend Its Plastics Units Proceeds?

Jan 12, 2007 • SA Editors • Comment!
Top Picks for 2007 from JPMorgan HealthCare Analysts

Jan 12, 2007 • Centient Biotech Investor • 1 Comment
Invitrogen Falls Hard on Earnings Miss

Oct 29, 2006 • H.S. Ayoub • Comment!
Barron's: Invitrogen May Outperform An Already Strong Industry

Sep 17, 2006 • SA Editor Eli Hoffmann • Comment!
Biotech IPO: Highlights from Rosetta Genomics' F1 Filing

Sep 10, 2006 • Evelyn Rubin • Comment!

Invitrogen Corp. (IVGN)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers